134 related articles for article (PubMed ID: 2698488)
1. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
Klinger M; Szewczyk Z
Przegl Lek; 1989; 46(12):816-21. PubMed ID: 2698488
[No Abstract] [Full Text] [Related]
2. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
Orlowski T; Rancewicz Z; Lao M; Juskowa J; Klepacka J; Gradowska L; Morzycka-Michalik M; Glyda J
Klin Wochenschr; 1988 Oct; 66(20):1019-23. PubMed ID: 3148785
[TBL] [Abstract][Full Text] [Related]
4. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
Klinger M; Szewczyk Z
Przegl Lek; 1989; 46(10):744-9. PubMed ID: 2687950
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
[TBL] [Abstract][Full Text] [Related]
7. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
8. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
Naumovic R; Furuncic D; Jovanovic D; Stosovic M; Basta-Jovanovic G; Lezaic V
Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study.
Yuan J; Fang W; Zhang W; Ni Z; Qian J
Nephrology (Carlton); 2011 May; 16(4):440-5. PubMed ID: 21091923
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
11. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
12. Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis.
Cattran DC
Clin Nephrol; 1991; 35 Suppl 1():S43-7. PubMed ID: 1860267
[TBL] [Abstract][Full Text] [Related]
13. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).
Mohácsi G; Magori A; Sonkodi S
Int Urol Nephrol; 1988; 20(3):315-25. PubMed ID: 3403200
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa; Biriukova LS; Makurov AI
Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
[No Abstract] [Full Text] [Related]
16. Retreatment of membranous nephropathy with steroids and chlorambucil after initial unresponsiveness to alternate-day prednisone.
Tietjen DP
Clin Nephrol; 1990 Mar; 33(3):152. PubMed ID: 2323113
[No Abstract] [Full Text] [Related]
17. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
Riabov SI; Stavskaia VV; Sheveleva LA
Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
[TBL] [Abstract][Full Text] [Related]
18. [The therapy of mesangiocapillary glomerulonephritis].
Ratner MIa; Fedorova ND; Biriukova LS; Makurov AI
Ter Arkh; 1995; 67(8):10-2. PubMed ID: 7482319
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
20. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
